Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 7/20 | 0.77 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.77 |
| ▸ | NQO2 | P16083 | 5/20 | 0.77 |
| ▸ | ESR1 | P03372 | 4/20 | 0.77 |
| ▸ | TTR | P02766 | 4/20 | 0.77 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.77 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.77 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.77 |
| ▸ | TUBB | P07437 | 3/20 | 0.77 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.77 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.77 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.77 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.77 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.77 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.77 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.77 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.77 |
| ▸ | TUBA1A | Q71U36 | 3/20 | 0.77 |
| ▸ | TUBA1C | Q9BQE3 | 3/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12667489 | 1.00 | CYP1A1 (0.77) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL10312395 | 0.92 | RELA (0.68) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL13409620 | 0.92 | RELA (0.81) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL8206188 | 0.89 | CYP1A1 (0.62) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL8206185 | 0.89 | CYP1A1 (0.62) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL12729821 | 0.89 | PTGS2 (0.80) | CYP1A1CYP1B1NQO2ESR1TTR | |
| Trismethoxyresveratrol SCHEMBL918740 | 0.87 | CYP1A1 (1.00) | CYP1A1CYP1B1NQO2ESR1TTR | |
| 8Z-3,4',5-Trimethoxystilbene SCHEMBL1006207 | 0.87 | CYP1A1 (1.00) | CYP1A1CYP1B1NQO2ESR1TTR | |
| Trismethoxyresveratrol SCHEMBL918739 | 0.87 | CYP1A1 (1.00) | CYP1A1CYP1B1NQO2ESR1TTR | |
| SCHEMBL10097227 | 0.85 | RELA (1.00) | CYP1A1CYP1B1NQO2ESR1TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023150072-A1 | COMPOSITIONS AND METHODS FOR THE PRESERVATION OF PLANT MATTER | SINCLAIR DAVID A (US) | 2023-08-10 | — | — | WO | disclosed |
| US-8912234-B2 | Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol | UNIAO Brasileria de Educacao e Assistencia—Mantenedora da PUCRS (BR) | 2014-12-16 | — | — | US | disclosed |
| US-20130040920-A1 | COMPOSITION CONTAINING RESVERATROL AND/OR DERIVATIVES THEREOF AND PLANT OIL, PROCESS FOR PRODUCING SAID COMPOSITION, NUTRACEUTICAL AND/OR PHARMACEUTICAL PRODUCT, AND METHOD FOR ENHANCING THE POTENTIAL OF RESVERATROL | UNIAO Brasileira de Educacao e Assistencia- Matenedora da PUCRS (BR) | 2013-02-14 | — | — | US | disclosed |
| WO-2008157537-A2 | COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS | IRONWOOD PHARMACEUTICALS, INC (US) | 2008-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130040920-A1 | COMPOSITION CONTAINING RESVERATROL AND/OR DERIVATIVES THEREOF AND PLANT OIL, PROCESS FOR PRODUCING SAID COMPOSITION, NUTRACEUTICAL AND/OR PHARMACEUTICAL PRODUCT, AND METHOD FOR ENHANCING THE POTENTIAL OF RESVERATROL | GPR119, MAVS, SIRT1 | CYP1A1 1104/4885CYP1B1 1838/4885NQO2 945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.